Literature DB >> 1678401

Attaching and effacing enteropathogenic Escherichia coli as a cause of infantile diarrhea in Bangkok.

P Echeverria1, F Orskov, I Orskov, S Knutton, F Scheutz, J E Brown, U Lexomboon.   

Abstract

To identify Escherichia coli that cause infantile diarrhea in Bangkok, Thailand, E. coli isolated in a year-long study of infantile diarrhea were examined for O and H serotypes and virulence determinants. Classic enteropathogenic E. coli (EPEC) were isolated from 28 of 509 infants with diarrhea (cases) and 11 of 509 age-matched controls (P = .009; odds ratio [OR], 2.64). Most of this difference was attributable to EPEC adherence factor (EAF)-positive EPEC that produced an attachment and effacement lesion, as identified in the fluorescence actin staining assay, isolated from 13 cases and 1 control (P = .003; OR, 13.3). EAF-EPEC was isolated from 15 cases and 10 controls (P = .418; OR, 1.52) and EAF+ non-EPEC from 17 cases and 10 controls (P = .242; OR, 1.72). EAF+EPEC that caused an attachment and effacement lesion was found in 3% of children less than 6 months old with diarrhea who were studied in an outpatient clinic in Bangkok in 1988.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678401     DOI: 10.1093/infdis/164.3.550

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Phylogenetic backgrounds and virulence profiles of atypical enteropathogenic Escherichia coli strains from a case-control study using multilocus sequence typing and DNA microarray analysis.

Authors:  Jan Egil Afset; Endre Anderssen; Guillaume Bruant; Josée Harel; Lothar Wieler; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

3.  Use of an alkaline phosphatase-conjugated oligonucleotide probe for the gene encoding the bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  K Nagayama; Z Bi; T Oguchi; Y Takarada; S Shibata; T Honda
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Rapid modulation of electrolyte transport in Caco-2 cell monolayers by enteropathogenic Escherichia coli (EPEC) infection.

Authors:  G K Collington; I W Booth; S Knutton
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

5.  Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR.

Authors:  Jan Egil Afset; Guillaume Bruant; Roland Brousseau; Josée Harel; Endre Anderssen; Lars Bevanger; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells.

Authors:  M S Donnenberg; J Yu; J B Kaper
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

7.  Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; F Qadri; T Azim; K J Jarvis; J B Kaper; M J Albert
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Differentiation in virulence patterns of Escherichia coli possessing eae genes.

Authors:  H Schmidt; B Plaschke; S Franke; H Rüssmann; A Schwarzkopf; J Heesemann; H Karch
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

9.  Attaching-effacing lesions and intracellular penetration in HeLa cells and human duodenal mucosa by two Escherichia coli strains not belonging to the classical enteropathogenic E. coli serogroups.

Authors:  M Z Pedroso; E Freymüller; L R Trabulsi; T A Gomes
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  Enteropathogenic Escherichia coli O157 strains from Brazil.

Authors:  T Eric Blank; David W Lacher; Isabel C A Scaletsky; Hailang Zhong; Thomas S Whittam; Michael S Donnenberg
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.